Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus (HPAIV) from the 2021/22 epizootic is highly duck adapted and poorly adapted to chickens.
J Gen Virol
; 104(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37167079
3.
Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay.
Virus Res
; 339: 199262, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931881
4.
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Vaccines (Basel)
; 11(1)2022 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679903
5.
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses.
Viruses
; 13(8)2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452443
6.
Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.
Bio Protoc
; 11(21): e4236, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34859134
7.
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.
Sci Immunol
; 5(54)2020 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33361161